Cell therapy
Titre original de l'avis
Spain – Pharmaceutical products – Suministro de medicamentos destinados a diversas terapias avanzadas para el Servicio Canario de la Salud
Score d'opportunité
Pourquoi ce score ?
Opportunité
65 / 100
Complexité
40 / 100
Facteurs de risque
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Dirección General de Recursos Económicos del Servicio Canario de la Salud
- Pays
- Espagne
- CPV
- 33600000 - Pharmaceutical products +1 autres
- Date limite
- Mar 12, 2030
- Valeur estimée
- EUR 40M
Aperçu
Strong opportunityFaits clés
- EUR 40M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of advanced therapy medicinal products (cell therapy) for the Canary Health Service.
- Coverage of various and diverse advanced therapies as technology and research evolve.
Afficher le résumé complet
This tender by the Canary Health Service (Dirección General de Recursos Económicos del Servicio Canario de la Salud) is for the supply of advanced therapy medicinal products (cell therapy) via a Dynamic Purchasing System (DPS) under a restricted procedure. The estimated total value is €40,037,508, with a single lot covering various advanced therapies. The deadline for submission is 2030-03-12, providing a long bidding period. Award is based solely on price (100% weight). The tender is conducted in Spanish and appears EU-funded per structured data, though the XML notice indicates no EU funds. Only the TED XML notice was analyzed; full procurement documents are missing.
Risques
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Supplies of pharmaceutical products classified under CPV 33600000 and 33690000.
- Contract period from 2025-03-12 to 2030-03-12 (5 years).
Administrative
- Electronic submission required.
Critères d'attribution
Lot 1
Acheteur
Localisation
Las Palmas de Gran Canaria, ESP
Profil acheteur
Identifiant
21058580149618
Activité
Health
Lots (1)
LOT-0000
Cell therapy
Supply of various advanced therapy medicinal products (cell therapy) for the Canary Health Service, covering evolving needs as technology and research advance.
EUR 40M
Valeur estimée
Localisation
Catégorie
Critères d'attribution
Date limite
Détails des critères
Precio. . Terapia celular.
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Titre original du lot
Terapia celular
Description TED originale
Suministro de medicamentos destinados a diversas y variadas terapias avanzadas
Détails de la procédure
- Date de publication
- 12 Mar 2025
- Langues
- Spanish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 163196-2025
Documents (1)
Appels d'offres similaires
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Score d'opportunité
Pourquoi ce score ?
Opportunité
65 / 100
Complexité
40 / 100
Facteurs de risque
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications